Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis

H. Tan, P. Gupta, J. Harness, R. Wolk, S. Chapel, A. Menter, B. Strober, R. G. Langley, S. Krishnaswami, K. A. Papp

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases